Login

Verisec's Freja Emerges as Top Choice for UK Public Sector Identity Management | Johan Henrikson , CEO & Co-founder at Verisec AB 00:10:00

Share On Facebook Share On Twitter

Johan Henrikson is the CEO & Co-founder at Verisec AB

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Liberty Gold's Transition to Exploration and Development at Black Pine
00:10:00
Justifying Your Fees as a Fee-Only Advisor
00:10:00
The Uranium market and its potential for growth and investment opportunities|Brandon Munro,CEO,Bannerman Energy
00:10:00
DrillCo's Revolutionary Clean Tech Modular Drilling System Unveiled
00:10:00
Western Australian Manganese Developer Poised for High-Purity Market Entry
00:10:00
Great Southern Copper Unveils Promising Exploration Results at Suyay Prospect, Chile | Sam Garrett, CEO, Great Southern Copper PLC.
00:10:00
Akoustis Technologies, Inc. (OTCQB: AKTS) | Jeffrey Shealy, CEO, Akoustis Technologies IncAKTS:NAQ
00:10:00
AAK AB Q2 2024 Interim Report: CEO Johan Westman’s Commentary | Johan Westman, CEO , AAK AB.
00:00:00
Carlos Ponce, MD, PhD Assistant Professor of Neurobiology, HMS
00:10:00
Volume driven by electric vehicle growth, surging lithium demand, and the evolving landscape for battery supply chains|Kent Masters,CEO,Albemarle
00:10:00
Krsnaa Diagnostics Ltd. IPO: A Deep Dive into the Company’s Business and Financials | Yash Mutha, Director ,Krsnaa Diagnostics Ltd.
00:10:00
Alastair Unwin, Deputy Fund Manager of Polar Capital Technology Trust - Navigating Interest Rate Trends and Harnessing AI for Strategic Technology Investments

© 2026 Nehu